A, S., & RIK, A. (2026). Redefining breast cancer: Therapeutic opportunities in HER2-low and emerging molecular subtypes. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04508-0
Chicago Style (17th ed.) CitationA, Shadab, and Al-Shdefat RIK. "Redefining Breast Cancer: Therapeutic Opportunities in HER2-low and Emerging Molecular Subtypes." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04508-0.
MLA (9th ed.) CitationA, Shadab, and Al-Shdefat RIK. "Redefining Breast Cancer: Therapeutic Opportunities in HER2-low and Emerging Molecular Subtypes." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04508-0.
